INTRODUCTION: In DISCOVER-2, guselkumab, an interleukin-23 p19 subunit inhibitor, was efficacious in biologic-naïve psoriatic arthritis (PsA) patients. We report the effect of guselkumab on health-related quality of life...
INTRODUCTION: The phase 3 DISCOVER-2 trial evaluated the effect of guselkumab on impaired work productivity and nonwork activity in biologic-naïve patients with psoriatic arthritis (PsA).
METHODS: Adults with active PsA...
INTRODUCTION: The phase 3 DISCOVER-2 trial evaluated the effect of guselkumab on impaired work productivity and nonwork activity in biologic-naïve patients with psoriatic arthritis (PsA).
METHODS: Adults with active PsA...
INTRODUCTION: In DISCOVER-2, guselkumab, an interleukin-23 p19 subunit inhibitor, was efficacious in biologic-naïve psoriatic arthritis (PsA) patients. We report the effect of guselkumab on health-related quality of life...
The evaporation of a sessile droplet of liquid is a complex and multifaceted fundamental topic of enduring scientific interest that is key to numerous physical and biological processes. As a result, in recent decades a...
The evaporation of a sessile droplet of liquid is a complex and multifaceted fundamental topic of enduring scientific interest that is key to numerous physical and biological processes. As a result, in recent decades a...
|< |
< |
1 |